Clinical outcomes and correlates of TP53 mutations and cancer.

Cold Spring Harbor perspectives in biology

Volumn 2, Issue 3, 2010, Pages

  Robles, Ana I ^a   Harris, Curtis C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PYRIMIDINE DIMER;

DNA MICROARRAY; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MUTATION; NEOPLASM; NUCLEOTIDE SEQUENCE; PROGNOSIS; REVIEW; RISK; SUNLIGHT; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

BIOLOGICAL MARKERS; DNA MUTATIONAL ANALYSIS; GENES, P53; GENETIC VARIATION; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PYRIMIDINE DIMERS; RISK; SUNLIGHT; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77955382651     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a001016     Document Type: Review

References (110)